ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228 | -95.4% | 10,927 | -94.7% | 0.00% | -90.9% |
| Q2 2023 | $4,950 | -1.4% | 206,656 | -22.5% | 0.01% | -8.3% |
| Q1 2023 | $5,018 | +283.6% | 266,644 | +224.6% | 0.01% | +300.0% |
| Q4 2022 | $1,308 | -100.0% | 82,139 | -51.5% | 0.00% | -62.5% |
| Q3 2022 | $2,773,000 | -65.9% | 169,506 | -51.3% | 0.01% | -50.0% |
| Q4 2021 | $8,125,000 | -31.2% | 348,107 | -51.1% | 0.02% | -33.3% |
| Q3 2021 | $11,812,000 | -32.9% | 711,167 | -1.4% | 0.02% | -33.3% |
| Q2 2021 | $17,599,000 | -23.1% | 721,546 | -18.6% | 0.04% | -28.0% |
| Q1 2021 | $22,882,000 | -45.8% | 886,913 | +12.3% | 0.05% | -49.0% |
| Q4 2020 | $42,237,000 | +32.1% | 790,077 | +1.9% | 0.10% | +15.3% |
| Q3 2020 | $31,975,000 | – | 775,152 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |